(Q49069734)

18 February 2018

title

Sonographic basal ganglia alterations are related to non-motor symptoms in multiple sclerosis. (English)

1 reference

18 February 2018

0 references

Uwe Walter

4

0 references

author name string

Sebastian Horowski

series ordinal

1

1 reference

18 February 2018

Uwe K Zettl

series ordinal

2

1 reference

18 February 2018

Reiner Benecke

series ordinal

3

1 reference

18 February 2018

publication date

26 August 2010

1 reference

18 February 2018

published in

Journal of Neurology

1 reference

18 February 2018

volume

258

1 reference

18 February 2018

issue

2

1 reference

18 February 2018

page(s)

195-202

1 reference

18 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-010-5707-0

exact match

0 references

cites work

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

A multimodal approach to managing the symptoms of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Structural brain abnormalities in multiple sclerosis patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Transcranial sonography findings related to non-motor features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Overactive bladder in Parkinson's disease: alteration of brainstem raphe detected by transcranial sonography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Transcranial brain sonography findings predict disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Urge incontinence: new health-related quality of life measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Vulnerability of the nigrostriatal system as detected by transcranial ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Transcranial brain parenchyma sonography in movement disorders: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Multiregional brain iron deficiency in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Learning processing in the basal ganglia: a mosaic of broken mirrors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5707-0

Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction.

21 January 2018

1 reference

12 December 2020

The Face-Symbol Test and the Symbol-Digit Test are not reliable surrogates for the Paced Auditory Serial Addition Test in multiple sclerosis

1 reference

12 December 2020

Brain MRI lesions and atrophy are related to depression in multiple sclerosis

1 reference

12 December 2020

Test-retest reliability of the Urge-Urinary Distress Inventory and Female Sexual Function Index in women with multiple sclerosis.

1 reference

12 December 2020

Lesion pattern in patients with multiple sclerosis and depression

1 reference

12 December 2020

Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging

1 reference

12 December 2020

Contemporary ultrasound systems allow high-resolution transcranial imaging of small echogenic deep intracranial structures similarly as MRI: a phantom study

1 reference

12 December 2020

Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography

1 reference

12 December 2020

Screening for major depression in the early stages of multiple sclerosis

1 reference

12 December 2020

The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force

1 reference

12 December 2020

10.1007/S00415-010-5707-0

Identifiers

DOI

1 reference

18 February 2018

Dimensions Publication ID

1017965476

0 references

1 reference

18 February 2018